Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03577691 · ClinicalTrials.gov registry record · NA
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03577691: Clinical Trial NA study, sponsored by Emory University.
NCT03577691 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03577691, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The trial is a prospective, randomized study to determine the efficacy of training for use of a web based Decision Aid for Hydroxyurea(HU) usage among subjects with Sickle Cell Disease(SCD). Subjects are randomized primarily either to using a web based decision aid with training versus without training. Subjects in each group will be further randomized to 1) subjects receiving pretest surveys; and 2) subjects that do not receive pretest surveys.
Primary Outcome
Subjects knowledge will be tested by using a knowledge Survey that was given at baseline and at 4 weeks follow up phone call. It is a 27 True, False or Unsure questionnaire that tests subjects knowledge of understanding risk for severe lung disease (pulmonary hypertension). This test is administered to both groups that are in turn randomized to to receive the pretest AND posttest or just the posttest surveys.
Interventions
- OTHER Training for use of web based Decision Aid
- OTHER No training for use of web based Decision Aid
- OTHER Pretest surveys and posttest surveys
- OTHER Only posttest surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-08-03 |
| Est. Completion | 2019-07-03 |
| Phase | NA |
Why NCT03577691 stopped before completion
NCT03577691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Training for use of web based Decision Aid is the first listed.
NCT03577691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03577691 about?
NCT03577691 is a clinical study titled "Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease". The trial is a prospective, randomized study to determine the efficacy of training for use of a web based Decision Aid for Hydroxyurea(HU) usage among subjects with Sickle Cell Disease(SCD). Subjects are randomized primarily either to using a web based decision aid with training versus without train...
What is the current status of trial NCT03577691?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-08-03. Estimated completion is 2019-07-03.
What interventions are being tested in trial NCT03577691?
The interventions under investigation include: Training for use of web based Decision Aid (OTHER), No training for use of web based Decision Aid (OTHER), Pretest surveys and posttest surveys (OTHER), Only posttest surveys (OTHER).
Who is sponsoring clinical trial NCT03577691?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03577691's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI